NDC Code(s) : 51662-1290-1, 51662-1290-2, 51662-1290-3
Packager : HF Acquisition Co LLC, DBA HealthFirst
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| ADRENALIN (EPINEPHRINE)ADRENALIN (EPINEPHRINE) INJECTION | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| LABELER - HF Acquisition Co LLC, DBA HealthFirst(045657305) |
| REGISTRANT - HF Acquisition Co LLC, DBA HealthFirst(045657305) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| HF Acquisition Co LLC, DBA HealthFirst | 045657305 | relabel(51662-1290) | |
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 1 mL Vial Label
NDC 42023-159-25
Rx Only
Adrenalin®
(epinephrine
injection, USP)
1 mg/mL
NOT for Ophthalmic Use
1 mL Single-Use Vial

Adrenalin 1 mL vial label
PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL
NDC 51662-1290-2 Pouch Label

PRINCIPAL DISPLAY PANEL
NDC 51662-1290-3 Case Label

PRINCIPAL DISPLAY PANEL








